Insights provides context and perspective about key pharmacy trends and issues

Care Management
The Rise of GLP-1s to Improve Metabolic Health
New CVS Caremark white paper describes the reasons for the rapid increase in utilization of GLP-1 drugs to treat diabetes and obesity. More
Briefing
Cost Management
Next in Gene Therapy: 2024 Roundup
An update on the gene therapy pipeline More
Briefing
Health Equity
Understanding Disparities in Alzheimer’s Disease and Dementia
Understanding and addressing root causes of disparities in Alzheimer’s and dementia can help advance health equity and improve health outcomes More
Briefing
Care Management
Metabolism Matters: Building a Blueprint for Improved Outcomes
Diabetes and obesity result from poor metabolic health and are associated with more than 200 chronic diseases. Focusing on metabolic health can help to improve health status overall. More
Briefing
Innovation
What You Need to Know About PBMs
CVS Health PBM More
Briefing
Cost Management
Maximize your savings through the power of integration
Integration saves money for you and your members, delivers administrative simplicity and enhances opportunities for member support. More
Briefing
Cost Management
2024 CVS Caremark Formulary Updates
... More
Briefing
Drug Pipeline
Drugs to Watch: Anticipated Q4 2023 Launches
The drug pipeline continues to flow. See what new therapies are expected to launch in the fourth quarter of 2023. More
Briefing
Drug Pipeline
Getting personal with mRNA cancer vaccines
Getting personal with mRNA vaccines for cancer More
Briefing
Cost Management
Gene Therapy for Sickle Cell Disease
Gene therapy to treat sickle cell disease could soon be a reality More
Briefing